Britain Approves Human Cloning

By EMMA ROSS

LONDON (AP) — Britain granted its first license for human cloning Wednesday, more than three years after becoming the first nation to authorize the technique to produce stem cells for medical research.

A team of researchers at Newcastle University hope eventually to create insulin-producing cells that could be transplanted into diabetic patients.

Britain became the first country to authorize the cloning of human embryos when Parliament voted in 2001 to allow regulators to license the method to scientists investigating the medical promise of stem cells, the master cells of the body.

The South Korean parliament followed in December, and by February scientists there announced they had become the first in the world to successfully clone a human embryo and extract stem cells for research.

The stem cells are extracted when the embryo is still microscopic. British regulations allow the embryo to develop for no more than 14 days, after which the embryo starts to develop a nervous system.

Many scientists believe stem cells hold vast promise for treating an array of diseases from diabetes to Parkinson’s and Alzheimer’s. Stem cells can potentially grow into any type of human tissue and scientists hope to be able to direct the blank cells to grow into specific cell types needed for transplant.

The United States prohibits any kind of embryo cloning and has lobbied strongly against it. The Bush administration also has restricted funding for stem cell research, which has become an issue in the U.S. presidential campaign.

U.S. policy forbids federal funding for research on embryonic stem cell lines created after Aug. 9, 2001. Democratic presidential nominee Sen. John Kerry has said that if elected he would overturn those funding restrictions.

Some Christian and politically conservative groups oppose stem cell research – especially cloning – as immoral because fertilized embryos must be destroyed to harvest the stem cells.

Stem cells can be found in adults, but scientists believe they may not be as versatile as those found in embryos. They envision using cloning to create an embryo cloned from a patient so that stem cells extracted would be a perfect transplant match.

“After careful consideration of all the scientific, ethical, legal and medical aspects of the project, the Human Fertilization and Embryology Authority License Committee agreed to grant an initial one year research license to the Newcastle Center for Life,” the British regulator said in a statement.

“This is an important area of research and a responsible use of technology. The HFEA is there to make sure any research involving human embryos is scrutinized and properly regulated.”

Regulations on cloning and stem cell research vary around the world. No other European country licenses the practice.

In Japan, the government’s top science council voted last month to adopt policy recommendations that would permit limited cloning of human embryos for stem cell research in Japan.

This year, the United Nations will revisit the issue of whether to propose an international treaty to ban “therapeutic” cloning – which produces stem cells from cloned embryos – as well as “reproductive” cloning, which makes babies.

—–

On the Net:

Human Fertilization and Embryology Authority

More science, space, and technology from RedNova

Copyright © 2004 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten or redistributed without the prior written authority of The Associated Press.